Clinical expertise

Dr Laura Price is an integral member of the National Pulmonary Hypertension Service at Royal Brompton Hospital, consulting with patients who have all subtypes of pulmonary hypertension and other pulmonary vascular diseases.

She has special interests in pulmonary hypertension related to the following lung conditions:

She runs outpatient pulmonary hypertension clinics and supervises the care of inpatients with the condition with emergencies relating to pulmonary hypertension or co-existing medical conditions.

Dr Price runs a follow up clinic for patients after pulmonary emboli (blood clots in the lungs) at Royal Brompton Hospital, with input from haematology colleagues.

Dr Price is also happy to see patients with general respiratory problems including breathlessness and cough.


Dr Laura Price is a consultant respiratory physician at Royal Brompton Hospital, where she treats both NHS and private patients.

She studied medicine at the University of Bristol, graduating in 1998, also obtaining an intercalated BSc in cellular and molecular pathology in 1995.

Further to her specialist experience in pulmonary hypertension, Dr Price has broad training in general, respiratory and critical care medicine. She also has experience in anaesthesia, obtaining her primary fellowship of the Royal College of Anaesthetists (FRCA) in earlier training posts.

She undertook specialist training in respiratory and general medicine on the North-West London rotation, centred at Royal Brompton Hospital, between 2005 and 2013. During this time, she also completed a PhD in pulmonary hypertension from Imperial College London. In 2008, she spent 12 months in the largest pulmonary hypertension centre in Europe (in Paris, France), gaining advanced clinical and research experience in the condition.


Dr Laura Price’s particular areas of research include:

  • pulmonary hypertension related to lung diseases, notably interstitial lung disease and sarcoidosis
  • non-invasive assessment using artificial intelligence of pulmonary hypertension in IPF.

Among several ongoing clinical projects, she is co-applicant on a National Institute for Health Research (NIHR) application to study the benefits of specific drugs in patients with ILD and pulmonary hypertension and co-supervised higher degree students at Imperial College London, most recently examining the impact of sildenafil in ILD-PH and assessing the power of serial change in non-invasive surrogates of pulmonary hypertension in patients with interstitial lung disease.

During her PhD studentship, Dr Price demonstrated that activation of the key inflammatory signalling molecule, NF-kappa B, was enhanced in the lungs of patients with idiopathic pulmonary arterial hypertension.

Further work using corticosteroids in a disease model and in relevant lung cells showed that suppression of inflammation pulmonary arterial hypertension might be a potential therapeutic target. Her PhD led to four well-cited peer-reviewed publications.


Dr Laura Price has over 15 years of experience in undergraduate and postgraduate teaching.

She is the education lead for the pulmonary hypertension team at Royal Brompton Hospital, frequently teaches junior doctors and medical students, and is an honorary clinical senior lecturer at the National Heart and Lung Institute at Imperial College London.


Dr Laura Price has written over 100 peer-reviewed articles, across a wide range of topics in respiratory disease (notably related to pulmonary hypertension and critical care), as well as authoring many book chapters.